<i>EGFR</i> Mutations and <i>ALK</i> Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective AnalysisJustin F. Gainor, Mari Mino–Kenudson, Christopher G. Azzoli et al.|Clinical Cancer Research|2016Cited by 1.2k
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLCAlexa B. Turke, Pasi A. Jänne, Kreshnik Zejnullahu et al.|Cancer Cell|2010Cited by 1.1k
Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trialAparna R. Parikh, Theodore S. Hong, Annamária Szabolcs et al.|Nature Cancer|2021Cited by 283
Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung CancerAnna F. Farago, Benjamin J. Drapkin, Beow Y. Yeap et al.|Cancer Discovery|2019Cited by 238
Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in <i>ROS1</i> Fusion–Positive Lung CancerJustin F. Gainor, Noura J. Choudhury, Satoshi Yoda et al.|Clinical Cancer Research|2021Cited by 137